46
Views
0
CrossRef citations to date
0
Altmetric
Articles

Disability and Opioids Among Pregnant Women

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-16 | Received 08 Feb 2022, Accepted 16 Nov 2022, Published online: 15 Dec 2022

References

  • Akobirshoev, I., Parish, S., Mitra, M., & Rosenthal, E. (2017). Birth outcomes among US women with intellectual and developmental disabilities. Disability and Health Journal, 10(3), 406–412.
  • Alexander, A. C., Waring, J. J. C., Olurotimi, O., Kurien, J., Noble, B., Businelle, M. S., Ra, C. K., Ehlke, S. J., Boozary, L. K., Cohn, A. M., & Kendzor, D. E. (2022). The relations between discrimination, stressful life events, and substance use among adults experiencing homelessness. Stress and Health, 38(1), 79–89. https://doi.org/10.1002/smi.3073
  • Altman, B., & Bernstein, A. (2008). Disability and health in the United States, 2001–2005. National Center for Health Statistics. https://www.cdc.gov/nchs/data/misc/disability2001-2005.pdf
  • American College of Obstetricians and Gynecologists (ACOG). (2017). Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. Obstet Gynecol, 130, 81–94.
  • Arnaudo, C. L., Andraka-Christou, B., & Allgood, K. (2017). Psychiatric co-morbidities in pregnant women with opioid use disorders: Prevalence, impact, and implications for treatment. Current Addiction Reports, 4(1), 1–13. https://doi.org/10.1007/s40429-017-0132-4
  • Babb, M., Koren, G., & Einarson, A. (2010). Treating pain during pregnancy. Can Family Physician, 56(1), 25–27.
  • Bateman, B. T., Hernandez-Diaz, S., Rathmell, J. P., Seeger, J. D., Doherty, M., Fischer, M. A., & Huybrechts, K. F. (2014). Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology, 120(5), 1216–1224. https://doi.org/10.1097/aln.0000000000000172
  • Bloom, T., Mosher, W., Alhusen, J., Lantos, H., & Hughes, R. (2017). Fertility desires and intentions among U.S. Women by Disability Status, 21(8), 1606–1615.
  • Booth, E. J., Kitsantas, P., Min, H., & Pollack, A. Z. (2021). Stressful life events and postpartum depressive symptoms in women with disabilities. Women’s Health, 17, 17455065211066110–17455065211066186. https://doi.org/10.1177/2F17455065211066186
  • Brown, H. K., Lunsky, Y., Wilton, A. S., Cobigo, V., & Vigod, S. N. (2016). Pregnancy in women with intellectual and developmental disabilities. Journal of Obstetrics and Gynaecology Canada, 38(1), 9–16.
  • Center for Behavioral Health Statistics and Quality (CBHSQ). (2018). 2016 National Survey on drug use and health public use file codebook. Substance Abuse and Mental Health Services Administration.
  • Centers for Disease Control and Prevention (CDC). (2020). Disability and health overview. https://www.cdc.gov/ncbddd/disabilityandhealth/disability.html
  • Centers for Disease Control and Prevention (CDC). (2021). Fentanyl. Opioid Basics. Opioid Overdose. https://www.cdc.gov/drugoverdose/opioids/index.html
  • Centers for Disease Control and Prevention (CDC). (2017a). Opioid Basics. https://www.cdc.gov/drugoverdose/opioids/prescribed.html
  • Centers for Disease Control and Prevention (CDC). (2017b). Opioid painkiller prescribing: Where you live makes a difference. https://www.cdc.gov/vitalsigns/opioid-prescribing
  • Centers for Disease Control and Prevention (CDC). (2020). Wide-ranging online data for epidemiologic research (WONDER). National Center for Health Statistics. http://wonder.cdc.gov
  • Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., Gilson, A. M., Kelter, A., Mauskop, A., O'Connor, P. G., Passik, S. D., Pasternak, G. W., Portenoy, R. K., Rich, B. A., Roberts, R. G., Todd, K. H., & Miaskowski, C. (2009). American Pain Society-American academy of pain medicine opioids guidelines panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The Journal of Pain, 10(2), 113–130.
  • DEA. (2022). Fentanyl awareness. Drug Enforcement Agency. Retrieved April 29, 2022, from https://www.dea.gov/fentanylawareness
  • Department of Health and Human Services (HHS). (2017). Determination that a Public Health Emergency Exists. https://www.hhs.gov/sites/default/files/opioid%20PHE%20Declaration-no-sig.pdf
  • Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014). Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstetrics and Gynecology, 123(5), 997–1002. https://doi.org/10.1097/AOG.0000000000000208
  • D’Souza, M. S. (2019). Brain and cognition for addiction medicine: From prevention to recovery neural substrates for treatment of psychostimulant-induced cognitive deficits. Frontiers in Psychiatry, 10, e00509. https://doi.org/10.3389/fpsyt.2019.00509
  • Ford, J. A., Hinojosa, M. S., & Nicholson, H. L. (2018). Disability status and prescription drug misuse among U.S. adults. Addictive Behaviors, 85, 64–69. https://doi.org/10.1016/j.addbeh.2018.05.019
  • Haight, S., Ko, J., Tong, V., Bohm, M., & Callaghan, W. (2018). Opioid use disorder documented at delivery hospitalization – United States, 1999–2014. Morbidity and Mortality Weekly Report, 67(31), 845–849. https://doi.org/10.15585/mmwr.mm6731a1
  • Halfon, N., & Hochstein, M. (2002). Life course health development: An integrated framework for developing health, policy, and research. The Milbank Quarterly, 80(3), 433–479, iii. https://doi.org/10.1111/1468-0009.00019
  • Halfon, N., DuPlessis, H., & Barrett, E. (2008). Looking back at pediatrics to move forward in obstetrics. Current Opinion in Obstetrics & Gynecology, 20(6), 566–573. https://doi.org/10.1097/GCO.0b013e3283184638
  • Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/M17-0865
  • Hayatbakhsh, M., Flenady, V., Gibbons, K., Kingsbury, A. M., Hurrion, E., Mamun, A. A., & Najman, J. M. (2012). Birth outcomes associated with cannabis use before and during pregnancy. Pediatric Research, 71(2), 215–219. https://doi.org/10.1038/pr.2011.25
  • Hudgins, J. D., Porter, J. J., Monuteaux, M. C., & Bourgeois, F. T. (2019). Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study. PLoS Medicine, 16(11), e1002922–15. https://doi.org/10.1371/journal.pmed.1002922
  • Jantarada, C., Silva, C., & Guimarães-Pereira, L. (2021). Prevalence of problematic use of opioids in patients with chronic noncancer pain: A systematic review with meta-analysis. Pain Practice, 21(6), 715–729. https://doi.org/10.1111/papr.13001
  • Kitsantas, P., Krall, J. R., Anand, P., Pollack, A. Z., Ramos, Y., & Kornides, M. (2020). Marijuana use among pregnant women with mental health-related disabilities. Women’s Reproductive Health, 7(1), 49–59. https://doi.org/10.1080/23293691.2019.1690307
  • Kitsantas, P., Adams, A. R., Cheema, J., & Kornides, M. L. (2021). Opioid use in pregnant women with mental health‑related disabilities. Archives of Gynecology and Obstetrics, 303(6), 1531–1537. https://doi.org/10.1007/s00404-020-05953-0
  • Ko, J. Y., D’Angelo, D. V., Haight, S. C., Morrow, B., Cox, S., Salvesen von Essen, B., Strahan, A. E., Harrison, L., Tevendale, H. D., Warner, L., Kroelinger, C. D., & Barfield, W. D. (2020). Vital signs: Prescription opioid pain reliever use during pregnancy – 34 U.S. Jurisdictions, 2019. Morbidity and Mortality Weekly Report, 69(28), 897–903. https://doi.org/10.15585/mmwr.mm6928a1
  • Kozhimannil, K. B., Graves, A. J., Levy, T., & Patrick, S. W. (2017). Nonmedical use of prescription opioids among pregnant U.S. women. Women’s health issues, 27(3), 308–315.
  • Krahn, G. L., Walker, D. K., & Correa-De-Araujo, R. (2015). Persons with disabilities as an unrecognized health disparity population. American Journal of Public Health, 105(S2), S198–S206. https://doi.org/10.2105/AJPH.2014.302182
  • Kuo, Y., Raji, M. A., & Goodwin, J. S. (2019). Association of disability with mortality from opioid overdose among US medicare adults. JAMA Network Open, 2(11), e1915638. https://doi.org/10.1001/jamanetworkopen.2019.15638
  • Liaw, V., Kuo, Y., Raji, M. A., & Baillargeon, J. (2020). Opioid prescribing among adults with disabilities in the United States After the 2014 federal hydrocodone rescheduling regulation. Public Health Reports, 135(1), 114–123. https://doi.org/10.1177/2F0033354919892638
  • Maryland Department of Health (MDH). (2020). Maryland Maternal Mortality Review: 2019 Annual Report. https://phpa.health.maryland.gov/mch/Documents/Health-General%20Article,%20%C2%A713-1207,%20Annotated%20Code%20of%20Maryland%20-%202019%20Annual%20Report%20%E2%80%93%20Maryland%20Maternal%20Mortality%20Review.pdf
  • McCabe, S. E., Boyd, C. J., Cranford, J. A., & Teter, C. J. (2009). Motives for nonmedical use of prescription opioids among high school seniors in the United States: Self-treatment and beyond. Archives of Pediatric Adolescent Medicine, 163(8), 739–744.
  • Metz, V., Brown, Q., Martins, S., & Palamar, J. (2018). Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use. Drug and Alcohol Dependence, 183, 261–266.
  • Mitra, M., Manning, S. E., & Lu, E. (2012). Physical abuse around the time of pregnancy among women with disabilities. Maternal and Child Health Journal, 16(4), 802–806.
  • Mitra, M., Clements, K. M., Zhang, J., Iezzoni, L. I., Smeltzer, S. C., & Long-Bellil, L. M. (2015). Maternal characteristics, pregnancy complications, and adverse birth outcomes among women with disabilities. Medical Care, 53(12), 1027–1032. https://doi.org/10.1097/MLR.0000000000000427
  • Mitra, M., Iezzoni, L., Zhang, J., Long-Bellil, L., Smeltzer, S., & Barton, B. (2015). Prevalence and risk factors for postpartum depression symptoms among women with disabilities. Maternal and Child Health Journal, 19(2), 362–372. https://doi.org/10.1007/s10995-014-1518-8
  • Mogren, I. M., & Pohjanen, A. I. (2005). Low back pain and pelvic pain during pregnancy: Prevalence and risk factors. Spine, 30(8), 983–991. https://doi.org/10.1097/01.brs.0000158957.42198.8e
  • Morden, N. E., Munson, J. C., Colla, C. H., Skinner, J. S., Bynum, J. P. W., Zhou, W., & Meara, E. R. (2014). Prescription opioid use among disabled medicare beneficiaries: Intensity, trends and regional variation. Medical Care, 52(9), 852–859. https://doi.org/10.1097/2FMLR.0000000000000183
  • National Center for Complementary and Integrative Health (NCCIH). (2020). Clinical practice guidelines. https://www.nccih.nih.gov/health/providers/clinicalpractice
  • Okoro, C. A., Hollis, N. D., Cyrus, A. C., & Griffin-Blake, S. (2018). Prevalence of disabilities and health care access by disability status and type among adults – United States, 2016. Morbidity and Mortality Weekly Report, 67(32), 882–887. https://doi.org/10.15585/mmwr.mm6732a3
  • Ozturk, O., Hong, Y., McDermott, S., & Turk, M. (2021). Prescription drug monitoring programs and opioid prescriptions for disability conditions. Applied Health Economics and Health Policy, 19(3), 415–428. https://doi.org/10.1007/s40258-020-00622-4
  • Richard, C. L., Love, B. L., Boghossian, N., Hardin, J., & McDermott, S. (2022). Are pregnant women with disability prescribed opioids more and at higher dosages than those without disability?: A retrospective cohort study of South Carolina Medicaid beneficiaries. Disability and Health Journal, 15(2), 101288. https://doi.org/10.1016/j.dhjo.2022.101288
  • Sanmartin, M. X., Ali, M. M., Chen, J., & Dwyer, D. S. (2019). Prescription opioid misuse, sources of opioids and reasons for opioid misuse among reproductive aged parenting women with major depressive episode. Addictive Behaviors, 98, 106057. https://doi.org/10.1016/j.addbeh.2019.106057
  • Sanmartin, M. X., Ali, M. M., Novak, P., & Chen, J. (2019). Sources and main motivations for prescription opioid misuse among reproductive-aged parenting women in the United States. Substance Use & Misuse, 54(8), 1332–1336. https://doi.org/10.1080/10826084.2019.1580294
  • Schepis, T. S., Wastila, L., Ammerman, B., McCabe, V. V., & McCabe, S. E. (2020). Prescription opioid misuse motives in US older adults. Pain Medicine, 21(10), 2237–2243. https://doi.org/10.1093/pm/pnz304
  • Substance Abuse and Mental Health Services Administration (SAMHSA). (2020). National Survey on Drug Use and Health (NSDUH). https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health
  • Trujillo-Tanner, C., Yorgason, J. B., Richardson, S., Redelfs, A. H., Hill, M., White, A., Stagg, B., Ehrlich, J. R., & Markides, K. S. (2022). Sensory impairments and social isolation among hispanic older adults: Towards culturally sensitive measurement of social isolation. The Journals of Gerontology, 2022, gbac001. https://doi.org/10.1093/geronb/gbac001
  • US Bureau of Labor Statistics (BLS). (2020). Population Level [CNP16OV]. FRED Available at https://fred.stlouisfed.org/series/CNP16OV
  • Virginia Department of Health (VDH). (2020). Health factors linked to maternal morbidity and mortality. https://www.vhha.com/research/2020/03/06/health-factors-linked-to-maternal-morbidity-and-mortality/
  • Wilson, N., Kariisa, M., Seth, P., Smith, H. I., & Davis, N. L. (2020). Drug and opioid involved overdose deaths – United States, 2017–2018. Morbidity and Mortality Weekly Report, 69(11), 290–297. https://doi.org/10.15585/mmwr.mm6911a4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.